The MUET application has enabled the increased standardization of medication safety initiatives across the VA system and may serve as a useful model for the development of pharmacovigilance tools by other large integrated health care systems.

No abstract

The Table shows hospitalization costs for drug-symptom pairs with 25 or more reports (36 of 4026 unique pairs [0.9%]). The most reported drug-symptom pairs were lisinopril-angioedema (406 reports [7.9%]), warfarin-hemorrhage (311 [6.1%]), and warfarin-gastrointestinal hemorrhage

In recent years, the refinement of two databases for ADR reporting has increased VA's capability to systematically monitor, track, and report ADRs across its national network of health care facilities. Linking the two databases has further strengthened those capabilities, enhancing medication safety practices and aiding in pharmacovigilance.

No abstract